STAND. COM. REP. NO. 735
Honolulu, Hawaii
, 2005
RE: H.B. No. 31
H.D. 2
Honorable Calvin K.Y. Say
Speaker, House of Representatives
Twenty-Third State Legislature
Regular Session of 2005
State of Hawaii
Sir:
Your Committee on Finance, to which was referred H.B. No. 31, H.D. 2, entitled:
"A BILL FOR AN ACT RELATING TO PRESCRIPTION DRUGS,"
begs leave to report as follows:
The purpose of this bill is to require manufacturers of prescription drugs to provide quarterly reports that disclose:
(1) The average wholesale price;
(2) The wholesale acquisition price;
(3) The average manufacturer price; and
(4) The best prices
of prescription drugs dispensed in the state.
The AARP Hawaii, ILWU Local 142, Kokua Council, and numerous concerned individuals testified in support of this bill. The Department of Human Services and Pharmaceutical Research and Manufacturers of America testified in opposition to this measure. The Attorney General commented on this bill.
As affirmed by the record of votes of the members of your Committee on Finance that is attached to this report, your Committee is in accord with the intent and purpose of H.B. No. 31, H.D. 2, and recommends that it pass Third Reading.
Respectfully submitted on behalf of the members of the Committee on Finance,
____________________________ DWIGHT TAKAMINE, Chair |
||